Archive: 2026/03

Infections in Immunosuppressed Patients: Unusual Organisms and Risks

Infections in Immunosuppressed Patients: Unusual Organisms and Risks

Immunosuppressed patients face deadly infections from rare organisms that don't affect healthy people. These infections often show no symptoms, making early testing crucial. Learn the unusual bugs, risks, and what to do if you're on steroids or transplant drugs.

Patent Litigation and Generic Entry: Why Disputes Delay Affordable Drug Launches

Patent Litigation and Generic Entry: Why Disputes Delay Affordable Drug Launches

Patent litigation routinely delays generic drug launches by years, costing patients billions. Despite FDA approval, legal battles, pay-for-delay deals, and patent thickets keep cheaper drugs off the market. This is how the system works-and why reform is urgently needed.

First Trimester Medication Safety: What You Need to Know About Critical Development Windows

First Trimester Medication Safety: What You Need to Know About Critical Development Windows

The first trimester is the most critical time for fetal development. Learn which medications are safe, which carry real risks, and how to make informed choices during early pregnancy.

Sulfonylureas and Weight Gain: What You Need to Know Long-Term

Sulfonylureas and Weight Gain: What You Need to Know Long-Term

Sulfonylureas help lower blood sugar but often cause weight gain - 2 to 5 kg on average. Learn why this happens, which drugs are worst, and how to fight it with smarter choices and lifestyle changes.

Professional Liability and Generic Substitution: How Pharmacists Can Reduce Risk

Professional Liability and Generic Substitution: How Pharmacists Can Reduce Risk

Generic drug substitution saves billions but increases legal risk for pharmacists. Learn how state laws, federal preemption, and patient communication affect liability-and what steps you can take to protect yourself and your patients.

Generic Drug Prices in the US vs Europe: Why Americans Pay Less for Off-Patent Medicines

Generic Drug Prices in the US vs Europe: Why Americans Pay Less for Off-Patent Medicines

Americans pay less for generic drugs than Europeans due to fierce market competition, while Europe’s regulated pricing keeps generic costs higher. This difference stems from structural contrasts in how each system handles drug pricing and competition.